Decreased interleukin-12 levels in umbilical cord blood in children who developed acute bronchiolitis

Pediatric Pulmonology

Volumn 28, Issue 3, 1999, Pages 175-180

  Blanco Quirós, Alfredo ^a,d   González, Hermenegildo ^b   Arranz, Eduardo ^a   Lapeña, Santiago ^c  

^a UNIVERSITY OF VALLADOLID   (Spain)

^b Hospital de Medina del Campo   (Spain)

^c Hospital of Leon   (Spain)

^d UNIVERSITY OF VALLADOLID   (Spain)

Author keywords

Asthma; Bronchiolitis; Cytokines; Interleukin 12; Neonates; Respiratory syncytial virus; Th1 Th2 cells; Wheezing

Indexed keywords

INTERLEUKIN 12;

ALLERGIC ASTHMA; ARTICLE; ATOPY; BRONCHIOLITIS; CLINICAL ARTICLE; CLINICAL FEATURE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE ASSOCIATION; HELPER CELL; HUMAN; IMMUNOPATHOGENESIS; NEWBORN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; UMBILICAL CORD BLOOD; WHEEZING;

ACUTE DISEASE; ANTIGENS, CD30; BRONCHIOLITIS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FETAL BLOOD; FOLLOW-UP STUDIES; HUMANS; INFANT; INFANT, NEWBORN; INTERLEUKIN-10; INTERLEUKIN-12; RESPIRATORY SOUNDS; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; T-LYMPHOCYTES;

EID: 0032874088     PISSN: 87556863     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-0496(199909)28:3<175::AID-PPUL3>3.0.CO;2-U     Document Type: Article

References (41)

1. Wohl MEB. Bronchiolitis. In: Chernick V, Kendig EL Jr, editors. Kendig's disorders of the respiratory tract in children, 5th ed. Philadelphia: W.B. Saunders; 1990. p 360-370.
2. Khan MA, Potter CW. The nPCR detection of Chlamydia pneumoniae and Chlamydia trachomatis in children hospitalized for bronchiolitis. J Infect 1996;33:173-175.
3. Hall CB, Douglas RG Jr. Clinically useful method for the isolation of respiratory syncytial virus. J Infect Dis 1975;131:1-5.
4. Kim HW, Arrobio JO, Brandt CD. Epidemiology of respiratory syncytial virus infection in Washington, DC. I. Importance of the virus in different respiratory tract disease syndromes and temporal distribution of infection. Am J Epidemiol 1973;98:216-225.
5. Welliver RC, Kaul TN, Ogra PL. The appearance of cell-bound IgE in respiratory-tract epithelium after respiratory-syncytial-virus infection. N Engl J Med 1980;303:1198-1202.
6. Welliver RC, Wong DT, Sun M, Middleton E, Vaughan RS, Ogra PL. The development of respiratory syncytial virus-specific IgE and the release of histamine in naso-pharyngeal secretions after infection. N Engl J Med 1981;305:841-846.
7. Kuikka L, Reijonen T, Remes K, Korppi M. Bronchial asthma after early childhood wheezing: A follow-up until 4.5-6 years of age. Acta Paediatr [Scand] 1994;83:744-748.
8. Godfrey S. Bronchiolitis and asthma in infancy and early child-hood. Thorax 1996;51:60-64.
9. Romagnani S. The Th1/Th2 paradigm. Immunol Today 1997;18: 263-266.
10. Rornagnani S. Lymphokine production by human T cells in disease states. Annu Rev Immunol 1994;12:227-257.
11. Allen JE, Maizels RM. Th1-Th2: reliable paradigm or dangerous dogma? Immunol Today 1997;18:387-392.
12. Robinson DS, Hamid Q, Ying S, Tsicopoulos A, Barkan J, Bentley A, Corrigan C, Durham SR, Kay AB. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 1992;326:298-304.
13. Tang MLK, Kemp AS, Thoburn J, Hill DJ. Reduced interferon-gamma secretion in neonates and subsequent atopy. Lancet 1994; 344:983-985.
14. Oppenshaw PJM, Clarke SL, Record FM. Pulmonary eosinophilic response to respiratory syncytial virus infection in mice sensitised to the major surface glycoprotein G. Int Immunol 1992;4:493-500.
15. Renzi PM, Turgeon JP, Yang JP, Drblik SP, Marcotte JE, Pedneault L, Spier S. Cellular immunity is activated and a TH-2 response is associated with early wheezing in infants after bronchiolitis. J Pediatr 1997;130:584-593.
16. Glezen WP, Taber LH, Frank AL. Risk of primary infection and reinfection with respiratory syncytial virus. Am J Dis Child 1986; 140:543-546.
17. Strannegard O, Cello J, Bjarnason R, Sigurbergsson F, Sigurs N. Association between pronounced IgA response in RSV bronchiolitis and development of allergic sensitization. Pediatr Allergy Immunol 1997;8:1-6.
18. Xiong H, Ohya S, Tanabe Y, Mitsuyama M. Persistent production of Interferon-gamma (IFN-gamma) and IL-12 is essential for the generation of protective immunity against Listeria monocytogenes. Clin Exp Immunol 1997;108:456-462.
19. Ma X, Aste-Amezaga M, Gri G. Immunomodulatory functions and molecular regulation of IL-12. In: Adorini L, editor. IL-12. Chemical immunology. Basel: Karger; 1997. p 1-22.
20. Halonen M, Martinez FD. A deficient capacity to produce interferon-gamma: is it a risk for asthma and allergies? Clin Exp Allergy 1997;27:1234-1236.
21. Naseer T, Minshall EM, Matin RJ, Laberge S, Ernst P, Martin RJ, Hamid Q. Expression of IL-12 and IL-13 mRNA in asthma and their modulation in response to steroid therapy. Am J Respir Crit Care Med 1997;155:845-851.
22. Hamid QA, Schotman E, Jacobson MR, Walker SM, Durham SR. Increases in (IL-12) messenger RNA+ cells accompany inhibition of allergen-induced late skin responses after successful grass pollen immunotherapy. J Allergy Clin Immunol 1997;99:254-260.
23. Hamid Q, Naseer T, Minshall EW, Song YL, Boguniewicz M, Leung DYM. In vivo expression of IL-12 and IL-13 in atopic dermatitis. J Allergy Clin Immunol 1996;98:225-231.
24. Hoekstra MO, Hoekstra Y, De Reus D, Rutgers B, Gerritsen J, Kauffman HF. Interleukin-4, interferon-gamma and interleukin-5 in peripheral blood of children with moderate atopic asthma. Clin Exp Allergy 1997;27:1254-1260.
25. Marzi M, Vigano A, Trabattoni D, Villa ML, Salvaggio A, Clerici E, Clerici M. Characterization of type 1 and type 2 cytokine production in physiologic and pathologic human pregnancy. Clin Exp Immunol 1996;106:127-133.
26. Glezen WP, Taber LH, Frank AL. Risk of primary infection and reinfection with respiratory syncytial virus. Am J Dis Child 1986; 140:543-546.
27. Gardner PS. How etiologic, pathologic, and clinical diagnoses can be made in a correlated fashion. Pediatr Res 1977;11:254-261.
28. Bui RH, Molinar GA, Kettering JD, Heiner DC, Imagawa DT, Gerne JN. Virus-specific IgE and IgG4 antibodies in serum of children infected with respiratory syncytial virus. J Pediatr 1987; 110:87-90.
29. Toms GL, Quinn R, Robinson JW. Undetectable IgE responses after respiratory syncytial virus infection. Arch Dis Child 1996; 74:126-130.
30. Strannegard O, Cello J, Bjarnason R, Sigurbergsson F, Sigurs N. Association between pronounced IgA response in RSV bronchiolitis and development of allergic sensitization. Pediatr Allergy Immunol 1997;8:1-6.
31. Balfour-Lynn I. Why do viruses make infants wheeze? Arch Dis Child 1996;74:251-259.
32. Howard M, O'Garra A. Biological properties of interleukin 10. Immunol Today 1992;13:198-200.
33. Fiorentino DF, Zlotnik A, Viera P, Mosmann TR, Howard M. Moore KW. IL-10 acts on antigen presenting cell to inhibit cytokine production by Th1 cells. J Immunol 1991;146:3444-3451.
34. Moore KW, O'Garra A, de Waal Malefyt R, Vieira P, Mosmann TR. Interleukin-10. Annu Rev Immunol 1993;11:165-190.
35. Del Prete G, De Carli M, Almerigogna F, Daniel CK, D'Elios MM, Zancuoghi G, Vinante F, Pizzolo G, Romagnani S. Preferential expression of CD30 by human CD4+ T cells producing Th2-type cytokines. FASEB J 1995;9:81-86.
36. Bengtsson A, Holm L, Back O, Fransson J, Scheynius A. Elevated serum levels of soluble CD30 in patients with atopic dermatitis (AD). Clin Exp Immunol 1997;109:533-537.
37. Leonard C, Tormey V, Faul J, Burke CM, Poulter LW. Allergen-induced CD30 expression on T cells of atopic asthmatics. Clin Exp Allergy 1997;27:780-786.
38. Gemou-Engesaeth V, Kay AB, Bush A, Corrigan CJ. Activated peripheral blood CD4 and CD8 T-lymphocytes in child asthma: correlation with eosinophilia and disease severity. Pediatr Allergy Immunol 1994;5:170-177.
39. Martinez FD. Role of viral infections in the inception of asthma and allergies during childhood: could they be protective? Thorax 1994;49:1189-1191.
40. Martinez FD, Morgan WJ, Wright AL, Holberg CJ, Taussig LM. Diminished lung function as a predisposing factor for wheezing respiratory illness in infants. N Engl J Med 1988;391:1112-1117.
41. Martinez FD, Morgan WJ, Wright AL, Holberg CJ, Taussig LM. Initial airway function is a risk factor for recurrent wheezing respiratory illness during the first three years of life. Am Rev Respir Dis 1991;143:312-316.